Chhea Chhorvann, MD. MPH. PhD Surveillance Unit, NCHADS

Similar documents
HIV Drug Resistance Surveillance: Early Warning Indicators Surveillance and Data management Units, NCHADS. Presented by Dr.

CHAI Cambodia: HIV Program Update NCHADS Annual Operational Comprehensive Planning Workshop Dec 3, 2012

KINGDOM OF CAMBODIA NATION RELIGION KING. FORTH QUARTERLY COMPREHENSIVE REPORT, 2013 HIV/AIDS and STI PREVENTION, CARE and TREATMENT PROGRAMME

KINGDOM OF CAMBODIA NATION RELIGION KING. SECOND QUARTERLY COMPREHENSIVE REPORT, 2014 HIV/AIDS and STI PREVENTION, CARE and TREATMENT PROGRAMME

HIV Drug Resistance (HIVDR)

Technical guidance for Round 9 Global Fund HIV proposals

KINGDOM OF CAMBODIA NATION RELIGION KING. THIRD QUARTERLY COMPREHENSIVE REPORT, 2013 HIV/AIDS and STI PREVENTION, CARE and TREATMENT PROGRAMME

Dr Mean Chhi Vun NCHADS Director

WHO HIV Drug Resistance Prevention and Assessment Strategy. Dr Richard Banda Technical Officer, HIV Drug Resistance WHO Inter-country Support Team

Kingdom of Cambodia Nation Religion King

WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean

KINGDOM OF CAMBODIA NATION RELIGION KING SECOND QUARTERLY COMPREHENSIVE REPORT, 2009 HIV/AIDS & STI PREVENTION AND CARE PROGRAMME

KINGDOM OF CAMBODIA NATION RELIGION KING THIRD QUARTERLY COMPREHENSIVE REPORT, 2011 HIV/AIDS & STI PREVENTION AND CARE PROGRAMME

Epidemiological Fact Sheet on HIV and AIDS. Core data on epidemiology and response. Cambodia Update

National HSS among ANC and MSM 2014

HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016

WHO HIV Drug Resistance Strategy

Presentation by: Dr. Mun Phalkun, Surveillance unit, NCHADS

Ministry of Health. National Center for HIV/AIDS, Dermatology and STD. Report of a Consensus Workshop

Drug and Health Care Delivery: A perspective from Cambodia and Ethiopia

No. individuals current on treatment (ART) - PEPFAR Indicator Reference Sheets

Technical Guidance Note for Round 11 Global Fund HIV Proposals

KINGDOM OF CAMBODIA NATION RELIGION KING SECOND QUARTERLY COMPREHENSIVE REPORT, 2011 HIV/AIDS & STI PREVENTION AND CARE PROGRAMME

HIV Drug Resistance Regional Update Eastern & Southern African Region

Guide for implementation of Positive Prevention among PLHIV in Cambodia

HIV Sentinel Surveillance

World Health Organization Strategy for HIV Drug Resistance Surveillance in Low- and Middle- Income Countries

Working Document on Monitoring and Evaluating of National ART Programmes in the Rapid Scale-up to 3 by 5

2004 Update. Cambodia

Description of d4t toxicities among 3 OI/ART clinics patients on ARV in Cambodia

Pediatric HIV/AIDS Care Sihanoukville Province

CO-SPONSORS. PMTCT Joint Program Review Report, October

Acceptance of Family Planning Methods among women coming to referral hospitals for abortion and post abortion care in Cambodia

Situation of the HIV Epidemic in Cambodia

Using mobile bus and ACASI to conduct an HIV behavioral serosurvey among urban men in Eight Cambodia Cities

Community Client Tracing Through Mentor Mothers in the Democratic Republic of the Congo

Women by area: Rural F Women by region: Banteay Mean Chey F

Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania

Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV

HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region

This work was supported by a grant from NIH: R21NR011131

CAMBODIA. Vitamin and Mineral Nutrition Information System (VMNIS)

Country profile. Population: ~ 87 million 63 provinces

increased efficiency. 27, 20

Kingdom of Cambodia Nation Religion King Ministry of Health

HIV Sentinel Surveillance (HSS) 2003: Results, Trends, and Estimates

The role of a Pharmacist in the analysis of adherence rates and associated factors in HIV-patients registered on Centralized Chronic Medicines

Kingdom of Cambodia Nation Religion King. Ministry of Health. Annual Report National Center for HIV/AIDS, Dermatology and STD

An Evaluation of Sexually Transmitted Infection Case Management in Health Facilities in 4 Border Provinces of Cambodia

Successes and remaining barriers to routine TB screening and implementation of IPT in Cambodia

Community Client Tracing Through Community Health Workers in Côte d Ivoire

Report of First Regional Clinicians Network Meeting for OIs and ART for Adults

STRENGTHENING SOCIAL ACCOUNTABILITY

HIV DRUG RESISTANCE AND STEWARDSHIP 3 RD LINE PROGRAMME

PAHO HIV REPORT. Progress of Implementation of the World Health Organization. Drug Resistance Strategy. in Latin America and the Caribbean:

Scale up the provision of comprehensive PMTCT services, using the Linked Response approach in Cambodia

Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV

HIV Quality Improvement Initiatives in Mozambique

Dr. Mercy Maina, Bpharm Pharmacovigilance Pharmacist USAID- AMPATH 1/17/2014 1

Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project

Using Data from Electronic HIV Case Management Systems to Improve HIV Services in Central Asia

HIV testing for Children

HIV DRUG RESISTANCE IN AFRICA

Quality of health facility data in the PMTCT cascade in Côte d Ivoire

Standard Operating Procedures (SOP) for Quality Improvement (QI) for HIV Counseling and Quality Control (QC) for HIV Testing

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE

SIAPS Cameroon Key Achievements

Discussion. Definition of Impact Analytic issues surrounding impact measures

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

No. NS/RKT/0905/396 ROYAL DECREE ON THE ESTABLISHMENT OF DENTAL COUNCIL. We, Preah Bat Norodom Sihanouk, King of the Kingdom of Cambodia,

The Genetic Barrier to Resistance

IPT BOTSWANA EXPERIENCE

CAMBODIAN HOUSEHOLD MALE SURVEY (JULY 2001)

Using Routine Health Information to Improve Voluntary Counseling and Testing in Cote d Ivoire

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

Assessing the Impact of HIV/AIDS: Information for Policy Dialogue

TECHNICAL UPDATE HIV DRUG RESISTANCE HIV DRUG RESISTANCE SURVEILLANCE GUIDANCE: 2015 UPDATE

Clinical Outcomes of Single Tablet vs. Multi-Tablet Antiretroviral Regimens in HIV-Infected Individuals

A I D S E p I D E m I c u p D A t E a S I a ASIA china India

Relationship between Demographic Factors, Stage of Disease and Adherence among HIV/AIDS Patients Receiving Highly Active Antiretroviral Therapy

Implementing a priority national health care project in Russian Federation (HIV prevention and treatment)

targets for HIV-positive children

Mariza Vono Tancredi. Eliseu Alves Waldman

HIV drug resistance and tracing outcomes among antiretroviral therapy defaulters in Malawi

Dr. Pascal Nji Atanga MD, MPH, PhD(c) University of Buea/Center for International Health, Ludwig Maximillians University Muenchen, Germany

Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV. Mon Mari Mon Visa : Men as Change Agents in Côte d Ivoire

Miami-Dade County Getting to Zero HIV/AIDS Task Force Implementation Report

TECHNICAL ASSISTANCE TO EXPAND HIV PREVENTION, CARE, AND TREATMENT IN NAMPULA, MOZAMBIQUE

Financial Incentives, Linkage to Care and Viral Suppression HPTN 065 (TLC-Plus) Study. Wafaa El-Sadr ICAP at Columbia University New York, NY

HIV Monitoring and Evaluation Quarterly Report: Technical Report. British Columbia Centre for Excellence in HIV/AIDS

Nationwide scale-up of IPT and ART amongst TB patient in Cambodia: Successes and challenges

CARE FOR HIV PATIENTS IN RURAL SOUTH AFRICA

Progress against the HIV Epidemic: is the end in sight?

Service coverage and mortality along the HIV care cascade in rural Uganda

Integrating PMCT in RH / MCH services in Myanmar. 6 November 2006 At Kuala Lumpur

I know it because I live it An In-clinic peer mentorship scheme to improve outcomes in adolescents living with HIV

State of Alabama HIV Surveillance 2014 Annual Report

CCTs and HIV care: Preliminary results and priority areas for intervention

HIV/AIDS Prevention. HIV/AIDS Research Agenda Workshop. Sunway Hotel, Phnom Penh March 28-29, Chhea Chhorvann M.

Response to HIV LOGISTICAL AND OTHER PERSPECTIVES

Transcription:

Chhea Chhorvann, MD. MPH. PhD Surveillance Unit, NCHADS

HIV prevalence among general population in Cambodia has been declining from 1.2% 2%in 2003 to 0.9% in 2006 Despite HIV/AIDS epidemic started in 1990, antiretroviral treatment (ART) provision was initiated in 2003 At the end of quarter 4, 2008, there were already about 28,932 patients (3,067 children) on ART at 51 OI/ART facilities 2

In 2006, Cambodia started implementing strategies to minimize the emergence of HIV drug resistance including; The continuous supply of WHO pre-qualified ARV drug ART provision using evidence-based standard highly active ART Adherence support Removal barriers to continuous access to ART Prevention program to reduce HIV transmission from person on ART 3

Because of high mutation rate of HIV, it is expected that some degree of HIV Drug Resistance (HIV DR) will occur among person on ART The degree of transmission of resistant strains depends on many factors; Degree of treatment success on a population Degree of Success of prevention program Degree of Success of ART program effort In 2003, one study from Pasteur Institute of Cambodia: of 144 newly infected ARV naïve people, 4.9% had drug resistance mutations to ARV drugs. 4

HIV DR surveillance typically includes 3 components; 1. Monitoring of early warning indicators (EWIs) 2. Surveillance of primary HIV DR transmission through threshold survey of recently infected people 3. Monitoring of secondary HIV DR occurring among patients on ART at sentinel sites 5

EWI#1: Percentage of months in which there were no ARV drug stock outages EWI#2: Percentage of months no expired ARV drug was found at ART site EWI#2b: : Percentage of months no emergency request for ARV drug was found at ART site EWI#3: ARV drugs are in storage conditions 6

EWI#4: Percentage of patients started on standard recommended first line ART regimen EWI#4b: Percentage of patients who started ART on a standard recommended first line regimen(among a cohort of patients who started ART in the past 12 months) EWI#5: Percentage of patients lost to follow up at 12 months after ART initiation EWI#6: Percentage of patients still on first line ART regimen 12 months after ART initiation EWI#7: Proportion of patients who kept all appointments 7

EWI will be collected from all ART sites in Cambodia. However, only 16 was selected in 2008 Matrix for ART sites were created based on the location, year started of ART sites, as well as number of AIDS patients served at the site ART sites were selected from each groups (if more than 2 ART sites were in the same group, random selection was used)

Provincial capital Remaining districts Large (>300) Small (<300) Large (>300) Small (<300) 2005 or earlier After 2005 2005 or earlier After 2005 2005 or earlier After 2005 2005 or earlier After 2005 Serey sophon Kompong speu Kompong Thom Social Health clinics SHV-RH Svay Rieng RH R5 Millitary (BTB) Kampong Kampot Kampot Poi pet Chheung Tmor Kol Chhnang RH (K-trach) Prey (BTB) Nak Loeng RH Sotnikum Koh Thom

Data are collected from ARV patient register ARV patient records Computer database (if available) Pharmacy records Inspection of the storage condition in the pharmacy Interview with clinicians Interview with patients who are on ARV

Adult sites (n=16) Pediatric sites (n=10) Urban (9) Rural (7) Urban (8) Rural (2) Median number of ARV patients used the 407 378 88 79 site (range) (192-1350) (160-600) (6-167) (8-150) Median number of OI/ARV patients served per day (range) 11 (10-40) 25 (10-45) 7 (1-20) Median number of staff at the ART site 9(5-32) 9(4-18) 5(4-9) 4 Median number of clinicians at the site 3 (2-7) 3 (1-5) 2 (2-3) 2 4 (3-4) Median ratio of total patients to 1 staff 45 (6-103) 33 (17-111) 19 (1-23) 19(2-37) Median days in a week ART site opens 5 (3-5) 5(3-5) 4.5 (1-5) 4.5(4-5) Median % of staff receiving any kind of incentive (range) 100% (70%-100%) 100% (50%-100%) 100% (28%-100% 50% (0%-50%) Median No. volunteers working at the site 3(0-6) 2(2-5) 2(0-6) 1 Median No. staff working in the pharmacy 2 (1-3) 2 (1-3) 1 (1-3) 1 Median No.HBC team working with the site 4 (0-16)* 3 (2-5) 6(0-16) 4(3-4) Percentage of site with separate pharmacy 89% 71% 75% 100% * Peer support groups work as HBC

Target: 100%

Target: 100%

Target 100%

Target 100% Note: One patient started treatment with 2 nd line regimen (he used to have 2 nd line drug from black market)

Target >80%

Target >80%

Target >80%

There still rooms need to be improved in terms of drug stock out, expired drug and storage condition Treatment is responsive since 100% of patients still be on 1 st line regimen at 12 moths after initiation The rates of lost to follow up at all sites are within an acceptable range Appointment keeping at some sites are below the target All patients started ART with recommended 1 st line regimen.

There is also problems at the Pediatric sites regarding drug stock out, expired drug and storage condition Good performance in terms of choices of ARV regimen used at the start of the treatment The percentage of children still on 1 st line regimen at 12 months after ARV initiation is good The proportion of patients who lost to follow up within 12 months was less than 20% Appointment keeping at many sites were out of an acceptable range (less than 80%)

There have had no significant warning signs related to the occurrence of HIV drug resistance yet in all visited ART sites However; ARV Drug management (drug supply, expired drug, storage) need to be improved There is a need to improve the appointment keeping rate, especially for children receiving ARV Issues such as, using different patient registers, different codes and incompleteness of the data should be solved immediately in order to make HIV DR surveillance more feasible.